Accelerate
small molecule Drug Discovery
Computational drug discovery services to help biotech and pharmaceutical companies improve the quality of their compound screening.
At Kvantify, we have developed a computational drug discovery platform to help biotech and pharmaceutical companies improve the quality of the compounds they test in the lab by leveraging proprietary, high-speed, accurate physics-based methods. We apply our bespoke algorithms and specialist expertise to optimise our customers' drug discovery pipeline.
From early Hit-Identification to Lead Optimisation phase, we help companies reduce their number of high-quality candidates from thousands to a handful.
Our vision for better therapeutics, faster
Most new drugs fail before they reach patients. Our vision is to revolutionize drug discovery with Kvantify's cutting-edge, physics-based platform, Koffee. The platform is designed to improve efficiency, reduce risks & time-to-market, and drive meaningful progress in developing new therapies - ultimately for the benefit of patients.
Based in physics
Our approach is grounded in physics-based modelling, with machine learning integration, but always anchored in physical principles. We prepare for the future of computing by re-engineering and optimising classical approaches, while developing the future quantum algorithms that will add further precision to computational drug discovery.
Our platform is well suited for rapid design-make-test-analyse cycles for compound design. By using cloud computing and our fully automated system preparation we can straightforwardly scale up to run large chemical libraries.
Collaborative research
Partner with us to enhance your pipeline projects using our proprietary tools and advanced methods. Our computational chemistry team will work closely with you to generate high-quality data, provide actionable insights, and guide your compound selection process.
